Medplant

Medplant is a resident of the Technopolice Moskva SEZ, a developer and manufacturer of a line of modern portable import-substituting medical products used in the provision of first and emergency medical care (stopping arterial bleeding, cardiopulmonary resuscitation, restoring and maintaining patency of the upper respiratory tract, monitoring life-threatening conditions, transport immobilization, evacuation and transportation of victims).

In total, as of February 2020, there are 31 registered medical devices and 14 patents for inventions. The company has the European a certificate ISO of 13485, a number of products are assigned European CE certificates. Medplant products are equipped with more than 20 thousand cars emergency medical care in all regions Russia and countries of the nearest abroad. The company's devices are also used in many medical institutions, in services, MINISTRY OF EMERGENCY SITUATIONS National Guard of the Russian Federation to medicine disasters and in the Armed Forces of the Russian Federation.

History

2024: Launch of electronics production for resuscitation medical equipment

Medplant, a resident of the Technopolice Moscow special economic zone, has opened a modernized workshop for the production of electronic modules for medical devices. This became known in early January 2025. The capacity of the new production will be 20 thousand modules annually.

According to the portal of the mayor of Moscow, the new workshop with an area of ​ ​ 600 square meters. meters is located on the Pechatniki site. Anatoly Garbuzov, Minister of the Moscow Government, Head of the Department of Investment and Industrial Policy, said that in the nine months of 2024 the company received ₽40 million tax benefits.

𝓲

Фото: mos.ru

Maxim Bagma, Deputy Head of Production, stressed that the company has launched a surface installation line for the independent manufacture of electronic modules, which will increase the localization of production. The modules will be used in cardiopulmonary resuscitation performance indicators, portable monitors and syringe dispensers.

The company developed and patented in 2024 a device for indirect massage of the heart with adaptation for various stiffness of the chest. Gennady Degtev, General Director of the Technopolice Moscow SEZ, noted that after receiving the registration certificate, mass production of the device will begin.

As part of the expansion of production facilities, the company reorganized the space, moving the sewing workshop to new premises and placing the modernized production of electronic medical devices on the vacant area.

Medplant, which received the status of a SEZ resident in 2018, uses tax incentives and customs preferences to invest in the development of innovative medical equipment. The production of electronic modules will provide components for various types of resuscitation and diagnostic equipment.^[1]

Notes